Clinical trial
ITT-PMS Extension An extension study of intrathecal therapy with monoclonal antibodies in progressive multiple sclerosis
To assess long-term stabilising effects of on neurological symptoms by regular IT administered monoclonal antibodies in MS.
| Category | Value |
|---|---|
| Study start date | 2012-10-16 |